Evidence-Based Review of Therapies in Multiple Myeloma

Michael Sebag, A. Keith Stewart, Ralph M. Meyer

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationEvidence-Based Hematology
PublisherJohn Wiley and Sons
Number of pages6
ISBN (Print)9781405157476
StatePublished - Feb 4 2009


  • Bortezomib superior to dexamethasone in relapsed/refractory myeloma
  • High dose therapy followed by stem cell transplant and improved outcomes
  • Lactate dehydrogenase (LDH)
  • Lenalidomide role in patients with relapsed or refractory myeloma
  • Literature-search strategy and inclusions
  • Multiplemyeloma (MM) - second most common hematological malignancy in adults
  • Phase III Trials comparing stem cell transplantation with conventional chemotherapy
  • Therapies in multiple myeloma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sebag, M., Stewart, A. K., & Meyer, R. M. (2009). Evidence-Based Review of Therapies in Multiple Myeloma. In Evidence-Based Hematology (pp. 390-395). John Wiley and Sons. https://doi.org/10.1002/9781444300857.ch50